[1] 段纪俊, 严亚琼, 杨念念, 等. 中国恶性肿瘤发病与死亡的国际比较分析[J].中国医学前沿杂志:电子版, 2016,8(7):17-23. [2] Chen W, Zheng RD, Baade PD, et al. Cancer Statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. [3] Siveen KS, Sikka S, Surana R, et al. Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J]. Biochim Biophys Acta, 2014,1845(2):136-154. [4] Luo Y, Cai X, Liu S, et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells[J]. Proc Natl Acad Sci USA, 2014,111(42):15178-15183. [5] Ding VA, Zhu Z, Xiao H, et al. The role of IL-37 in cancer[J]. Med Oncol, 2016,33(7):68. [6] 蒋娟, 邹勇德, 蒋福平, 等. IL-37对宫颈癌HeLa细胞增殖和凋亡的影响[J]. 肿瘤药学, 2014,4(4):263-266. [7] Wang S, An W, Yao Y, et al. Interleukin 37 expression inhibits STAT3 to suppress the proliferation and invasion of human cervical cancer cells[J]. J Cancer, 2015,6(10):962-969. [8] 陈荏槐, 胡新荣, 姚运红, 等. 新型抗炎因子IL-37真核表达载体pIRES2-EGFP/IL-37的构建及鉴定[J]. 广东医学院学报, 2014,32(5):607-609. [9] 孟祥凯, 郭毅, 唐艳君, 等. 治疗方案对宫颈癌患者生存质量影响的分析[J]. 中国妇幼保健, 2016, 31(12):2432-2434. [10] 罗利民, 赵展, 贾勇士, 等. 顺铂与奈达铂同步放化疗对中晚期宫颈癌的实效性对照探究[J]. 中华全科医学, 2016,14(3):365-367. [11] Luo YC, Cai XG, Liu SC, et al. 171:IL-37 suppresses contact hypersensitivity by inducing tolerogenic dendritic cells[J]. Cytokine, 2013,63(3):283. [12] 丁利平, 黎丽, 刘冬舟, 等. IL-37对白塞病患者单核细胞分泌炎症因子的影响[J]. 深圳大学学报:理工版, 2016,33(5):447-451. [13] Nold-Petry CA, Lo CY, Rudloff I, et al. IL-37 requires the receptors IL-18R[alpha] and IL-1R8(SIGIRR) to carry out its multifaceted anti-inflammatory programupon innate signal transduction[J]. Nat Immunol, 2015,16(4):354-365. [14] Zhou X, Ren Y, Liu A, et al. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis[J]. Sci Rep, 2014, 4:7461. [15] 陈晓, 韩凌霄, 王玉萍, 等. STAT3基因表达对宫颈癌HeLa细胞顺铂敏感性的影响[J]. 武警医学院学报, 2010,19(6):433-436. [16] Scheel A, Lin GC, Mchugh JB, et al. Human papillomavirus infection and biomarkers in sinonasal inverted papillomas:clinical significance and molecular mechanisms[J]. Int Forum Allergy Rhinol, 2015,5(8):701-707. [17] 丁沐阳,蒋文军,张力,等.EZH2抑制剂对宫颈癌HeLa细胞的抑制作用[J].西安交通大学学报:医学版,2015,36(5):633-635. |